IL1B and Alzheimer disease: Moreover, the increased production of IL-18 and IL-1β mediated by inflammasomes contributes to the onset and progression of RA, type II diabetes, and various neurodegenerative disorders, including Alzheimer’s disease (AD) and ALS51.